FR2343484A1 - Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant - Google Patents

Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant

Info

Publication number
FR2343484A1
FR2343484A1 FR7606821A FR7606821A FR2343484A1 FR 2343484 A1 FR2343484 A1 FR 2343484A1 FR 7606821 A FR7606821 A FR 7606821A FR 7606821 A FR7606821 A FR 7606821A FR 2343484 A1 FR2343484 A1 FR 2343484A1
Authority
FR
France
Prior art keywords
alanyl
parasites
viruses
acetyl
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7606821A
Other languages
English (en)
Other versions
FR2343484B1 (fr
Inventor
Francoise Audibert
Louis Chedid
Pierre Lefrancier
Jean Choay
Edgar Lederer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7606821A priority Critical patent/FR2343484A1/fr
Priority to US05/775,215 priority patent/US4153684A/en
Priority to DE2710455A priority patent/DE2710455C2/de
Priority to JP2553177A priority patent/JPS52116414A/ja
Publication of FR2343484A1 publication Critical patent/FR2343484A1/fr
Application granted granted Critical
Publication of FR2343484B1 publication Critical patent/FR2343484B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7606821A 1976-03-10 1976-03-10 Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant Granted FR2343484A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7606821A FR2343484A1 (fr) 1976-03-10 1976-03-10 Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant
US05/775,215 US4153684A (en) 1976-03-10 1977-03-07 Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
DE2710455A DE2710455C2 (de) 1976-03-10 1977-03-10 N-Acetylmuramyl-L-alanyl-D-glutaminsäure-alpha-methylamid, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
JP2553177A JPS52116414A (en) 1976-03-10 1977-03-10 22*22acetamidee22dioxyy33oodd glucopyranosyl**ddpropionyllllalanyll dd*alphaamethylamid**gultamine and adjuvants primaryly composed of same compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7606821A FR2343484A1 (fr) 1976-03-10 1976-03-10 Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant

Publications (2)

Publication Number Publication Date
FR2343484A1 true FR2343484A1 (fr) 1977-10-07
FR2343484B1 FR2343484B1 (fr) 1979-10-05

Family

ID=9170214

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7606821A Granted FR2343484A1 (fr) 1976-03-10 1976-03-10 Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant

Country Status (3)

Country Link
JP (1) JPS52116414A (fr)
DE (1) DE2710455C2 (fr)
FR (1) FR2343484A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005682A1 (fr) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Dérivés sililés de glucosamine, leur procédé de préparation et médicaments les contenant
EP0013856A1 (fr) * 1978-12-22 1980-08-06 ANVAR Agence Nationale de Valorisation de la Recherche Composés associant des restes peptidyliques ou aminoacylés à des groupes lipophyles et compositions pharmaceutiques les contenant
EP0025842A2 (fr) * 1979-07-31 1981-04-01 Fujisawa Pharmaceutical Co., Ltd. Peptides, procédé pour leur préparation, leurs compositions pharmaceutiques et leurs intermédiaires
EP0050703A2 (fr) * 1978-02-24 1982-05-05 Ciba-Geigy Ag Dérivés du glucose et méthode pour leur préparation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625067B2 (ja) * 1986-05-13 1994-04-06 全国農業協同組合連合会 子豚の離乳後下痢の感染防止法
CH680192A5 (fr) * 1989-12-13 1992-07-15 Nestle Sa

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH83A (fr) * 1888-11-17 1889-01-10 Fontainemelon Horlogerie Perfectionnements apportés à la construction des montres de tous calibres

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH83A (fr) * 1888-11-17 1889-01-10 Fontainemelon Horlogerie Perfectionnements apportés à la construction des montres de tous calibres

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1975 161 981Z CITE BIKEN J., 1975, 18, 105-111 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050703A2 (fr) * 1978-02-24 1982-05-05 Ciba-Geigy Ag Dérivés du glucose et méthode pour leur préparation
EP0050703A3 (en) * 1978-02-24 1982-06-02 Ciba-Geigy Ag Glucose derivatives, method for their preparation and their use
EP0005682A1 (fr) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Dérivés sililés de glucosamine, leur procédé de préparation et médicaments les contenant
WO1979001088A1 (fr) * 1978-05-18 1979-12-13 Ciba Geigy Ag Nouveaux derives de la glucosamine silylee et leur procede de preparation
EP0013856A1 (fr) * 1978-12-22 1980-08-06 ANVAR Agence Nationale de Valorisation de la Recherche Composés associant des restes peptidyliques ou aminoacylés à des groupes lipophyles et compositions pharmaceutiques les contenant
EP0025842A2 (fr) * 1979-07-31 1981-04-01 Fujisawa Pharmaceutical Co., Ltd. Peptides, procédé pour leur préparation, leurs compositions pharmaceutiques et leurs intermédiaires
EP0025842A3 (en) * 1979-07-31 1982-02-10 Fujisawa Pharmaceutical Co. Ltd. Peptides, process for their preparation, their pharmaceutical compositions and their intermediates

Also Published As

Publication number Publication date
FR2343484B1 (fr) 1979-10-05
DE2710455A1 (de) 1977-09-15
JPS52116414A (en) 1977-09-29
DE2710455C2 (de) 1986-04-03

Similar Documents

Publication Publication Date Title
KR880000098A (ko) 콘드로이틴 설페이트 면역자극 조성물
DE69432929D1 (de) Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
FR2343484A1 (fr) Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant
KR960017670A (ko) 결정성 세펨 산부가염 및 이의 제조방법
JPS5551020A (en) Remedy for rheumatism
ES8504459A1 (es) Procedimiento para preparar factor de transferencia especifico a un virus determinado.
EP0373002A3 (fr) L'utilisation des acides thiazolidine-4-carboniques, substitués en position 2, pour le traitement de la cataracte
CA2224309A1 (fr) Nouveau vaccin multivalent a base de virus corona bovin et methode de traitement de l'infection au virus corona bovin
JPS5543030A (en) Prophylactic and remedy for microbial infection disease
FR2292486A1 (fr) Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes
EP0399358A3 (fr) Dérivés d'acide buténoique
FI822282A0 (fi) Foerfarande foer framstaellning av , -dialkyladamantyletylaminer med antivirus verkan
GB2020665A (en) Acyl-N-acetylmuramylpeptide- antigen conjugate
EP0365139A3 (fr) Acides choliques pour le traitement des infections virales
GB902659A (en) A process for the production of a derivative of thebaine
Closs et al. Experimental Murine Leprosy: IX. Antibodies Against Mycobacterium lepraemurium in C3H and C57BL Mice with Murine Leprosy and in Patients with Lepromatous Leprosy
US7335642B2 (en) Method for treating a viral infection related or a chemical toxin related hepatic injury with deltorphin D
CA2065889A1 (fr) Augmentation du debit choroidien
Dhurandhar et al. Pseudo second degree atrioventricular block with bradycardia. Successful treatment with quinidine.
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS56115724A (en) Prophilaxis and remedy for avian infectious coryza
FR2143588A1 (en) Goose hepatitis live vaccine - for active immunization of water fowl
EP0486944A3 (fr) Méthode d'inhibition de la croissance de tumeurs en utilisant l'éther diméthyl de xanthocilline X
Negroni et al. Virus-cell relationship in kidney tumours induced in golden hamsters by the Mill Hill polyoma virus
SU1069818A1 (ru) Способ профилактики гриппа

Legal Events

Date Code Title Description
ST Notification of lapse